Order Article Reprints

Krajewski W, Moschini M, Nowak Ł, Poletajew S, Tukiendorf A, Afferi L, Teoh J, Muilwijk T, Joniau S, Tafuri A, et al. Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit. Journal of Clinical Medicine. 2020; 9(10):3306. https://doi.org/10.3390/jcm9103306

Krajewski, Wojciech, Marco Moschini, Łukasz Nowak, Sławomir Poletajew, Andrzej Tukiendorf, Luca Afferi, Jeremy Teoh, Tim Muilwijk, Steven Joniau, Alessandro Tafuri, and et al. 2020. "Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit" Journal of Clinical Medicine 9, no. 10: 3306. https://doi.org/10.3390/jcm9103306

Krajewski, W., Moschini, M., Nowak, Ł., Poletajew, S., Tukiendorf, A., Afferi, L., Teoh, J., Muilwijk, T., Joniau, S., Tafuri, A., Antonelli, A., Gozzo, A., Mari, A., Di Trapani, E., Hendricksen, K., Alvarez-Maestro, M., Serrano, A. R., Simone, G., Zamboni, S., ... Zdrojowy, R., on behalf of the European Association of Urology–Young Academic Urologists (EAU–YAU) Urothelial Carcinoma Working Group. (2020). Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit. Journal of Clinical Medicine, 9(10), 3306. https://doi.org/10.3390/jcm9103306